PCR is an organisation dedicated to education and information in the field of cardiovascular therapies, most notably for cardiovascular intervention and interventional medicine. Its activities cover a large spectrum, from the organisation of annual Courses in Europe, Asia, the Middle East and Africa to editing a scientific journal, publishing textbooks as well as providing training seminars on thematic subjects. For more information, please visit

Transcatheter aortic valve replacement (TAVR) patients continue to benefit from an optimized pre- and post-procedural treatment strategy that utilizes the cusp overlap technique and the Evolut Pro and Pro+ TAVR valves, according to new findings presented at EuroPCR 2022 in Paris.

The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems.

Cardiologist heart

Patients with higher levels of extravalvular cardiac damage prior to TAVR or SAVR face a higher risk of dying within two years, according to new findings presented at EuroPCR 2022 in Paris.

Renal denervation is associated with improved blood pressure (BP) control and a reduced risk of adverse cardiovascular outcomes, according to two late-breaking clinical trials presented at EuroPCR 2022 in Paris. Both clinical trials focused on three-year data related to Medtronic’s Symplicity Spyral Renal Denervation (RDN) System, which was designed to lower BP through the use of a curling catheter that ablates overactive nerves.

Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.

“Robotics is, in all likelihood, the future of interventional cardiology," one specialist said. Full study results are expected in May.

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 

Cardiologist heart

Researchers evaluated data from 25 different randomized clinical trials, sharing their findings virtually at EuroPCR 2021. 

Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.

The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients.


Abbott’s transcatheter tricuspid valve repair system is a safe and effective approach to treating tricuspid regurgitation in heart patients with few other options, according to data published in The Lancet.

Around the web

Two companies serving medical imagers just had products cleared for marketing in the U.S.

Defendants in the case allegedly defrauded CMS for millions of dollars that were spent on luxury vehicles, real estate and more.

Surgeons at NYU Langone Health successfully transplanted two genetically engineered pigs hearts into recently deceased humans in June and July.

Trimed Popup
Trimed Popup